These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Properties of an LNA-modified ricin RNA aptamer. Förster C; Zydek M; Rothkegel M; Wu Z; Gallin C; Geßner R; Lisdat F; Fürste JP Biochem Biophys Res Commun; 2012 Mar; 419(1):60-5. PubMed ID: 22326915 [TBL] [Abstract][Full Text] [Related]
6. LNA derivatives of a kissing aptamer targeted to the trans-activating responsive RNA element of HIV-1. Lebars I; Richard T; Di Primo C; Toulmé JJ Blood Cells Mol Dis; 2007; 38(3):204-9. PubMed ID: 17300966 [TBL] [Abstract][Full Text] [Related]
7. Determination of affinity constants of locked nucleic acid (LNA) and DNA duplex formation using label free sensor technology. Möhrle BP; Kumpf M; Gauglitz G Analyst; 2005 Dec; 130(12):1634-8. PubMed ID: 16284662 [TBL] [Abstract][Full Text] [Related]
11. Application of locked nucleic acids to improve aptamer in vivo stability and targeting function. Schmidt KS; Borkowski S; Kurreck J; Stephens AW; Bald R; Hecht M; Friebe M; Dinkelborg L; Erdmann VA Nucleic Acids Res; 2004; 32(19):5757-65. PubMed ID: 15509871 [TBL] [Abstract][Full Text] [Related]
12. Aptamers targeted to an RNA hairpin show improved specificity compared to that of complementary oligonucleotides. Darfeuille F; Reigadas S; Hansen JB; Orum H; Di Primo C; Toulmé JJ Biochemistry; 2006 Oct; 45(39):12076-82. PubMed ID: 17002307 [TBL] [Abstract][Full Text] [Related]
13. Locked vs. unlocked nucleic acids (LNA vs. UNA): contrasting structures work towards common therapeutic goals. Campbell MA; Wengel J Chem Soc Rev; 2011 Dec; 40(12):5680-9. PubMed ID: 21556437 [TBL] [Abstract][Full Text] [Related]
14. Nucleic acid aptamers in human viral disease. Zhang Z; Blank M; Schluesener HJ Arch Immunol Ther Exp (Warsz); 2004; 52(5):307-15. PubMed ID: 15507871 [TBL] [Abstract][Full Text] [Related]
15. Surface plasmon resonance investigation of RNA aptamer-RNA ligand interactions. Di Primo C; Dausse E; Toulmé JJ Methods Mol Biol; 2011; 764():279-300. PubMed ID: 21748648 [TBL] [Abstract][Full Text] [Related]
17. The development and testing of aptamers for cancer. Barbas AS; White RR Curr Opin Investig Drugs; 2009 Jun; 10(6):572-8. PubMed ID: 19513946 [TBL] [Abstract][Full Text] [Related]
18. Aptamers against extracellular targets for in vivo applications. Pestourie C; Tavitian B; Duconge F Biochimie; 2005; 87(9-10):921-30. PubMed ID: 15963620 [TBL] [Abstract][Full Text] [Related]
19. The chemical biology of aptamers. Mayer G Angew Chem Int Ed Engl; 2009; 48(15):2672-89. PubMed ID: 19319884 [TBL] [Abstract][Full Text] [Related]
20. Aptamers--basic research, drug development, and clinical applications. Proske D; Blank M; Buhmann R; Resch A Appl Microbiol Biotechnol; 2005 Dec; 69(4):367-74. PubMed ID: 16283295 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]